91av

Don’t get used to it

IT MAY be possible to get morphine’s painkilling effects without having to
take ever larger doses—and, possibly, without risking withdrawal symptoms.
The finding turns conventional theories on their head.

Morphine kills pain by mimicking the body’s natural opiates, binding to
special ised receptors on nerve cells. When natural opiates bind to them, the
receptors are sucked inside the cell—a process called
endocytosis—and then return to the cell surface. But when morphine binds
to the receptors, it blocks endocytosis.

This was thought to prolong morphine’s effect and give it its power. “It
seemed like the last thing you’d want to do to is trigger endocytosis,” says
Jennifer Whistler of the University of California, San Francisco.

Whistler’s team set out to test this theory when they discovered that a
protein called DAMGO could trigger endocytosis of morphine-bound receptors. They
used a standard pain test in which a laser is focused on the tail of rats. The
rats normally flick their tails away in about two seconds.

Rats given morphine didn’t flick their tails for six seconds. But the effects
soon wore off. After four days on the same dose, the animals flinched after just
two seconds.

But when the researchers added a tiny trace of DAMGO to the morphine, the
results were dramatic. Even after a week, the animals’ response hardly changed
at all. By itself, though, DAMGO had no effect.

DAMGO can’t be used to treat people—it is too large to enter the
brain—but Whistler thinks drugs witht the same effect could be found. The
findings also have implications for related opiates such as heroin. Could
junkies get more bang for their buck with such a booster, for example?

Glen Hanson of the US National Institute on Drug Abuse isn’t sure.
Painkilling is different to the high such drugs create, he says. And whether
endocytosis affects withdrawal and addiction isn’t yet clear. “This raises a lot
of exciting issues,” he says. “There are going to be a ton of phenomena to
油Ա.”

  • More at:
    Cell (vol 32, p 829)